IL1F10 and systemic lupus erythematosus: To further elucidate the association of plasma IL‐38 and clinical and laboratory features in patients with SLE and the potential of plasma IL‐38 as a biomarker for SLE, we evaluated the relation of IL‐38 and the parameters and disease activity.